High Affinity Nanobodies Block SARS-CoV-2 Spike Receptor Binding Domain Interaction with Human Angiotensin Converting Enzyme

Thomas J. Esparza(Henry M. Jackson Foundation), David L. Brody(Washington University in St. Louis)

bioRxiv (Cold Spring Harbor Laboratory)

July 24, 2020

10.1101/2020.07.24.219857

Cited by 11

Related Papers

Detection of Blast-Related Traumatic Brain Injury in U.S. Military Personnel

|New England Journal of Medicine|2011|596

Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain

|Scientific Reports|2017|165

High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme

|Scientific Reports|2020|123

Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer’s related amyloid-beta pathology

|PLoS ONE|2022|16

Pharmacokinetics of Single Domain Antibodies and Conjugated Nanoparticles Using a Hybrid near Infrared Method

|International Journal of Molecular Sciences|2021|15